Perspective Therapeutics, Inc. (CATX)

Perspective Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	707	113	44	113	38	28
Market Cap Growth	670.32%	156.98%	-61.12%	200.36%	36.12%	11.35%
Enterprise Value	529	106	-12	50	36	22
PE Ratio	-	-2.42	-6.04	-33.30	-10.87	-5.36
PS Ratio	-2297.47	78.65	-	11.23	3.88	3.78
PB Ratio	3.08	1.50	0.72	1.68	6.57	3.60
P/FCF Ratio	-29.99	-2.97	-5.50	-35.09	-9.60	-5.06
P/OCF Ratio	-52.35	-3.06	-5.69	-39.79	-10.32	-5.47
EV/Sales Ratio	-1712.10	73.86	-	4.94	3.72	3.02
EV/EBITDA Ratio	-10.57	-2.21	1.67	-15.53	-11.06	-4.46
EV/EBIT Ratio	-10.31	-2.16	1.60	-14.66	-10.45	-4.30
EV/FCF Ratio	-22.35	-2.79	1.46	-15.43	-9.20	-4.05
Debt / Equity Ratio	0.01	0.03	0.01	0.01	0.18	-
Debt / EBITDA Ratio	-0.06	-0.05	-0.08	-0.24	-0.31	-
Debt / FCF Ratio	-0.12	-0.07	-0.07	-0.24	-0.26	-
Quick Ratio	12.54	0.68	25.45	36.66	2.93	5.94
Current Ratio	12.98	1.08	26.18	37.37	3.50	6.53
Asset Turnover	0.00	0.01	0	0.24	1.06	0.65
Interest Coverage	-531.34	-584.23	-	-	-	-
Return on Equity (ROE)	-45.60%	-46.40%	-11.40%	-8.80%	-56.10%	-55.60%
Return on Assets (ROA)	-38.50%	-40.80%	-10.90%	-8.20%	-37.70%	-45.60%
Return on Capital (ROIC)	-18.35%	-52.67%	-10.39%	-5.05%	-51.66%	-68.41%
Earnings Yield	-8.26%	-41.23%	-16.57%	-3.00%	-9.20%	-18.67%
FCF Yield	-3.29%	-33.68%	-18.17%	-2.85%	-10.42%	-19.77%
Buyback Yield / Dilution	-116.59%	-88.50%	-36.74%	-53.61%	-0.83%	-21.54%
Total Shareholder Return	-116.59%	-88.50%	-36.74%	-53.61%	-0.83%	-21.54%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).